SanDisk to buy Msystems for $1.3b

By SUSAN LERNER
July 31, 2006 11:16

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

In the second major takeover of an Israeli technology company in a week, Msystems agreed to be acquired by fellow flash memory company SanDisk in a stock deal valued at $36 a share, or a total of about $1.3 billion. Under the agreement, each share of Kfar Saba-based Msystems will be converted into 0.76368 of a share of SanDisk common stock, representing a 26% premium over the average closing price of Msystems' shares for the last 30 trading days. Completion of the transaction was expected in the fourth quarter subject to, among other things, Israeli court approval, regulatory approval and Msystems shareholder approval. Last week, in the biggest buyout ever of an Israeli technology company, Hewlett-Packard bought Mercury Interactive Corp. for $4.5b.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS